Related Experiment Video
Updated: Jun 27, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
An integrative genomic and proteomic approach to chemosensitivity prediction
Yan Ma1, Zhenyu Ding, Yong Qian
1Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506-9300, USA.
International Journal of Oncology
|December 17, 2008
Summary
A new algorithm integrates gene and protein expression to predict cancer cell drug sensitivity, improving prediction accuracy beyond current methods. This approach enhances the understanding of cellular behavior and clinical outcomes.
Area of Science:
- Computational biology
- Genomics
- Proteomics
Background:
- Current methods for predicting cell line chemosensitivity often rely on single data types, limiting predictive power.
- Integrating gene and protein expression profiles offers a more comprehensive view of cellular states.
Purpose of the Study:
- To develop and validate an algorithm for classifying cell line chemosensitivity using integrated transcriptional and proteomic profiles.
- To determine if combined gene and protein expression data enhance chemosensitivity prediction accuracy.
Main Methods:
- An integrative feature selection scheme was used to identify key determinants from genome-wide transcriptional data and 52 protein expression levels in 60 human cancer cell lines (NCI-60).
- Classifiers were generated for 118 anti-cancer drugs, predicting sensitivity, intermediate response, or resistance, independent of tissue origin.
Main Results:
- The integrated approach significantly improved classification accuracy for all 118 drugs compared to chance (P<0.001).
- 76 out of 118 classifiers demonstrated significant accuracy improvements over protein expression-based classifiers alone (P<0.05).
Conclusions:
- Integrated genomic and proteomic profiling significantly enhances chemosensitivity prediction performance.
- The developed analytical framework provides a novel method for identifying integrated gene and protein expression signatures to predict cellular behavior and clinical outcomes.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...